Symbols / ALUR
ALUR Chart
About
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 10.03M |
| Enterprise Value | 83.37M | Income | -32.33M | Sales | 17.21M |
| Book/sh | -10.68 | Cash/sh | 0.66 | Dividend Yield | — |
| Payout | 0.00% | Employees | 134 | IPO | — |
| P/E | — | Forward P/E | -1.40 | PEG | — |
| P/S | 0.33 | P/B | -0.06 | P/C | — |
| EV/EBITDA | -2.16 | EV/Sales | 4.84 | Quick Ratio | 0.87 |
| Current Ratio | 1.26 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -15.29 | EPS next Y | -0.48 | EPS Growth | — |
| Revenue Growth | -50.50% | Earnings | 2026-03-25 | ROA | -71.87% |
| ROE | — | ROIC | — | Gross Margin | 60.99% |
| Oper. Margin | -3.62% | Profit Margin | -187.87% | Shs Outstand | 14.94M |
| Shs Float | 4.59M | Short Float | 5.17% | Short Ratio | 4.91 |
| Short Interest | — | 52W High | 4.18 | 52W Low | 0.32 |
| Beta | -0.46 | Avg Volume | 2.77M | Volume | 212.10K |
| Target Price | $5.50 | Recom | Strong_buy | Prev Close | $0.71 |
| Price | $0.39 | Change | -45.86% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$5.50
Mean price target
2. Current target
$0.39
Latest analyst target
3. DCF / Fair value
$-22.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.39
Low
$3.00
High
$8.00
Mean
$5.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-24 | up | Chardan Capital | Neutral → Buy | $3 |
| 2025-11-20 | main | Chardan Capital | Neutral → Neutral | $3 |
| 2025-03-27 | main | Chardan Capital | Neutral → Neutral | $3 |
| 2025-03-21 | reit | Roth MKM | Buy → Buy | $16 |
| 2025-03-21 | main | Chardan Capital | Neutral → Neutral | $3 |
| 2024-11-14 | down | Chardan Capital | Buy → Neutral | — |
| 2024-10-02 | init | TD Cowen | — → Buy | $2 |
| 2024-09-06 | init | Roth MKM | — → Buy | $2 |
| 2024-08-22 | main | Chardan Capital | Buy → Buy | $3 |
| 2024-05-15 | main | Chardan Capital | Buy → Buy | $5 |
| 2024-04-04 | init | Chardan Capital | — → Buy | $5 |
| 2024-02-09 | init | Jefferies | — → Buy | $5 |
- Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? - Yahoo Finance Fri, 27 Feb 2026 08
- $ALUR stock is down 35% today. Here's what we see in our data. - Quiver Quantitative Mon, 02 Mar 2026 19
- Weight-loss company Allurion secures $3M, issues 5.3M new warrants - Stock Titan ue, 24 Feb 2026 08
- Why did Allurion stock surge over 50% today? - MSN Sun, 08 Mar 2026 08
- Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE - Business Wire Mon, 02 Mar 2026 14
- Allurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy - The Globe and Mail ue, 03 Mar 2026 08
- Market Movers | Winners: GMGI, TPET, BATL | Losers: AARD, ALUR, PULM - Trefis ue, 03 Mar 2026 05
- Intercontinental Exchange : NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - marketscreener.com Fri, 06 Mar 2026 22
- Allurion stock surges 40% on U.S. FDA approval - Investing.com Mon, 23 Feb 2026 08
- Allurion Technologies Received Notice of Delisting - TradingView Mon, 02 Mar 2026 14
- What's Going On With Allurion Stock On Wednesday? - Bitget Wed, 25 Feb 2026 08
- Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices - Business Wire ue, 03 Feb 2026 08
- Chardan Capital Upgrades Allurion Technologies (ALUR) - Nasdaq ue, 24 Feb 2026 08
- Allurion stock soars after FDA milestones and debt exchange announcement - Investing.com ue, 11 Nov 2025 08
- Allurion Technologies (ALUR) director sells $4.9k in shares - Investing.com Fri, 05 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 3212 | 4918 | — | Sale at price 1.48 - 1.58 per share. | DAVIN MICHAEL R | Director | — | 2025-12-04 00:00:00 | I |
| 1 | 3212 | — | — | Stock Gift at price 0.00 per share. | DAVIN MICHAEL R | Director | — | 2025-11-26 00:00:00 | D |
| 2 | 1856288 | 3100001 | — | Stock Award(Grant) at price 1.67 per share. | RTW INVESTMENTS, L.P. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-11-12 00:00:00 | I |
| 3 | 1492539 | 5000006 | — | Conversion of Exercise of derivative security at price 3.35 per share. | RTW INVESTMENTS, L.P. | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-11-05 00:00:00 | I |
| 4 | 8000 | 24484 | — | Purchase at price 3.06 per share. | GAUR SHANTANU | Chief Executive Officer | — | 2025-05-19 00:00:00 | D |
| 5 | 1492539 | 5000006 | — | Conversion of Exercise of derivative security at price 3.35 per share. | RTW INVESTMENTS, L.P. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-04-16 00:00:00 | I |
| 6 | 8000 | 26800 | — | Purchase at price 3.35 per share. | GAUR SHANTANU | Chief Executive Officer | — | 2025-03-28 00:00:00 | D |
| 7 | 306749 | — | — | Stock Award(Grant) at price 0.00 per share. | GIBBONS BRENDAN M | Officer | — | 2024-11-08 00:00:00 | D |
| 8 | 306749 | — | — | Stock Award(Grant) at price 0.00 per share. | BUCH OJAS | Chief Operating Officer | — | 2024-11-08 00:00:00 | D |
| 9 | 326086 | — | — | Stock Award(Grant) at price 0.00 per share. | JOHNS KEITH B II | Director | — | 2024-11-08 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 5.55M | 2.41M | -172.41K | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.00 |
| NormalizedEBITDA | -29.91M | -82.73M | -31.46M | -12.35M |
| TotalUnusualItems | 26.44M | 11.48M | -821.00K | 4.34M |
| TotalUnusualItemsExcludingGoodwill | 26.44M | 11.48M | -821.00K | 4.34M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -7.20M | -82.82M | -37.74M | -12.39M |
| ReconciledDepreciation | 746.00K | 746.00K | 895.00K | 707.00K |
| ReconciledCostOfRevenue | 10.61M | 11.97M | 13.48M | 9.05M |
| EBITDA | -3.47M | -71.24M | -32.28M | -8.01M |
| EBIT | -4.22M | -71.99M | -33.17M | -8.72M |
| NetInterestIncome | -2.26M | -10.57M | -4.43M | -3.67M |
| InterestExpense | 2.26M | 10.57M | 4.43M | 3.67M |
| NormalizedIncome | -28.09M | -91.89M | -37.10M | -16.72M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -7.20M | -82.82M | -37.74M | -12.39M |
| TotalExpenses | 82.31M | 132.54M | 96.22M | 50.74M |
| TotalOperatingIncomeAsReported | -50.20M | -79.08M | -32.01M | -12.50M |
| DilutedAverageShares | 2.25M | 1.42M | 1.86M | 1.86M |
| BasicAverageShares | 2.25M | 1.42M | 1.86M | 1.86M |
| DilutedEPS | -11.64 | -57.75 | -21.85 | -7.33 |
| BasicEPS | -11.64 | -57.75 | -21.85 | -7.33 |
| DilutedNIAvailtoComStockholders | -7.20M | -84.51M | -40.65M | -13.63M |
| NetIncomeCommonStockholders | -7.20M | -84.51M | -40.65M | -13.63M |
| PreferredStockDividends | 1.70M | 2.91M | 1.24M | |
| NetIncome | -7.20M | -82.82M | -37.74M | -12.39M |
| NetIncomeIncludingNoncontrollingInterests | -7.20M | -82.82M | -37.74M | -12.39M |
| NetIncomeContinuousOperations | -7.20M | -82.82M | -37.74M | -12.39M |
| TaxProvision | 718.00K | 264.00K | 143.00K | 0.00 |
| PretaxIncome | -6.48M | -82.55M | -37.60M | -12.39M |
| OtherIncomeExpense | 45.98M | 7.09M | -1.17M | 3.78M |
| OtherNonOperatingIncomeExpenses | 19.54M | -4.39M | -344.00K | -555.00K |
| SpecialIncomeCharges | 14.19M | 7.52M | 0.00 | 4.38M |
| OtherSpecialCharges | 8.71M | 21.53M | -4.38M | |
| RestructuringAndMergernAcquisition | -22.90M | -29.05M | 0.00 | |
| GainOnSaleOfSecurity | 12.25M | 3.96M | -821.00K | -37.00K |
| NetNonOperatingInterestIncomeExpense | -2.26M | -10.57M | -4.43M | -3.67M |
| InterestExpenseNonOperating | 2.26M | 10.57M | 4.43M | 3.67M |
| OperatingIncome | -50.20M | -79.08M | -32.01M | -12.50M |
| OperatingExpense | 71.70M | 120.58M | 82.74M | 41.69M |
| ResearchAndDevelopment | 17.37M | 27.69M | 16.97M | 5.73M |
| SellingGeneralAndAdministration | 54.33M | 92.88M | 65.77M | 35.96M |
| SellingAndMarketingExpense | 25.93M | 46.86M | 50.41M | 27.14M |
| GeneralAndAdministrativeExpense | 28.40M | 46.02M | 15.37M | 8.82M |
| OtherGandA | 28.40M | 46.02M | 15.37M | 8.82M |
| GrossProfit | 21.50M | 41.50M | 50.73M | 29.19M |
| CostOfRevenue | 10.61M | 11.97M | 13.48M | 9.05M |
| TotalRevenue | 32.11M | 53.47M | 64.21M | 38.24M |
| OperatingRevenue | 32.11M | 53.47M | 64.21M | 38.24M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 2.71M | 1.91M | 1.86M | 1.86M |
| ShareIssued | 2.71M | 1.91M | 1.86M | 1.86M |
| NetDebt | 20.33M | 606.00K | 48.78M | 300.00K |
| TotalDebt | 37.92M | 41.86M | 59.53M | 26.14M |
| TangibleBookValue | -77.98M | -71.30M | -32.31M | -92.26M |
| InvestedCapital | -42.27M | -32.65M | 24.15M | -66.11M |
| WorkingCapital | 8.29M | -609.00K | -32.48M | 5.71M |
| NetTangibleAssets | -77.98M | -71.30M | -32.31M | -34.28M |
| CapitalLeaseObligations | 2.21M | 3.21M | 3.07M | 0.00 |
| CommonStockEquity | -77.98M | -71.30M | -32.31M | -92.26M |
| PreferredStockEquity | 58.00M | 57.97M | ||
| TotalCapitalization | -42.27M | -71.30M | -29.21M | -32.28M |
| TotalEquityGrossMinorityInterest | -77.98M | -71.30M | -32.31M | -34.28M |
| StockholdersEquity | -77.98M | -71.30M | -32.31M | -34.28M |
| GainsLossesNotAffectingRetainedEarnings | -8.37M | 700.00K | 0.00 | |
| OtherEquityAdjustments | -8.37M | 700.00K | ||
| RetainedEarnings | -222.21M | -215.01M | -132.19M | -94.45M |
| AdditionalPaidInCapital | 152.60M | 143.01M | 99.88M | 2.14M |
| CapitalStock | 3.00K | 2.00K | 1.00K | 58.02M |
| CommonStock | 3.00K | 2.00K | 1.00K | 51.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 57.97M |
| TotalLiabilitiesNetMinorityInterest | 110.79M | 143.01M | 83.68M | 73.64M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 91.93M | 77.58M | 7.82M | 42.02M |
| OtherNonCurrentLiabilities | 50.31M | 68.51M | 2.55M | 900.00K |
| PreferredSecuritiesOutsideStockEquity | 39.12M | 39.12M | ||
| DerivativeProductLiabilities | 4.57M | 6.76M | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 37.05M | 2.31M | 5.27M | 2.00M |
| LongTermCapitalLeaseObligation | 1.34M | 2.31M | 2.16M | 0.00 |
| LongTermDebt | 35.71M | 3.10M | 2.00M | |
| CurrentLiabilities | 18.86M | 65.42M | 75.87M | 31.61M |
| CurrentDeferredLiabilities | 0.00 | 202.00K | ||
| CurrentDeferredRevenue | 0.00 | 202.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 869.00K | 39.55M | 54.27M | 24.14M |
| CurrentCapitalLeaseObligation | 869.00K | 908.00K | 905.00K | 0.00 |
| CurrentDebt | 38.64M | 53.36M | 24.14M | |
| OtherCurrentBorrowings | 38.64M | 53.36M | 24.14M | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 1.05M | 1.69M | 3.45M | 2.23M |
| PayablesAndAccruedExpenses | 16.95M | 24.19M | 18.15M | 5.04M |
| CurrentAccruedExpenses | 10.38M | 13.81M | 12.34M | 3.42M |
| InterestPayable | 0.00 | 489.00K | 0.00 | |
| Payables | 6.57M | 10.38M | 5.81M | 1.62M |
| AccountsPayable | 6.57M | 10.38M | 5.81M | 1.62M |
| TotalAssets | 32.81M | 71.71M | 51.37M | 39.35M |
| TotalNonCurrentAssets | 5.66M | 6.90M | 7.99M | 2.02M |
| OtherNonCurrentAssets | 1.11M | 505.00K | 2.71M | 311.00K |
| NetPPE | 4.55M | 6.39M | 5.28M | 1.71M |
| AccumulatedDepreciation | -4.36M | -3.56M | -2.85M | -1.99M |
| GrossPPE | 8.90M | 9.95M | 8.13M | 3.70M |
| Leases | 1.94M | 1.94M | 1.82M | 1.75M |
| ConstructionInProgress | 14.00K | 1.20M | 583.00K | 13.00K |
| OtherProperties | 2.08M | 3.01M | 2.90M | |
| MachineryFurnitureEquipment | 4.87M | 3.80M | 2.83M | 1.93M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 27.16M | 64.82M | 43.38M | 37.33M |
| OtherCurrentAssets | 1.24M | 2.41M | 2.49M | 1.94M |
| Inventory | 3.40M | 6.17M | 3.87M | 2.71M |
| FinishedGoods | 1.79M | 3.43M | 2.10M | 1.61M |
| WorkInProcess | 763.00K | 967.00K | 213.00K | 216.00K |
| RawMaterials | 848.00K | 1.78M | 1.56M | 890.00K |
| Receivables | 7.13M | 18.19M | 29.35M | 6.83M |
| AccountsReceivable | 7.13M | 18.19M | 29.35M | 6.83M |
| AllowanceForDoubtfulAccountsReceivable | -6.70M | -12.67M | -741.00K | -354.00K |
| GrossAccountsReceivable | 13.84M | 30.86M | 30.09M | 7.19M |
| CashCashEquivalentsAndShortTermInvestments | 15.38M | 38.04M | 7.68M | 25.84M |
| CashAndCashEquivalents | 15.38M | 38.04M | 7.68M | 25.84M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -65.59M | -65.59M | -48.53M | -15.24M |
| RepaymentOfDebt | -88.41M | -88.41M | 0.00 | -29.40M |
| IssuanceOfDebt | 88.48M | 88.48M | 30.95M | 48.47M |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 0.00 | 9.87M |
| CapitalExpenditure | -1.61M | -1.61M | -1.55M | -912.00K |
| InterestPaidSupplementalData | 8.04M | 8.04M | 3.48M | 1.32M |
| EndCashPosition | 38.42M | 38.42M | 8.02M | 26.02M |
| BeginningCashPosition | 8.02M | 8.02M | 26.02M | 12.31M |
| ChangesInCash | 30.40M | 30.40M | -17.99M | 13.70M |
| FinancingCashFlow | 95.99M | 95.99M | 30.54M | 28.95M |
| CashFlowFromContinuingFinancingActivities | 95.99M | 95.99M | 30.54M | 28.95M |
| NetOtherFinancingCharges | 95.70M | 95.70M | -548.00K | -522.00K |
| ProceedsFromStockOptionExercised | 213.00K | 213.00K | 132.00K | 523.00K |
| NetPreferredStockIssuance | 0.00 | 9.87M | ||
| PreferredStockIssuance | 0.00 | 9.87M | ||
| NetCommonStockIssuance | 0.00 | 0.00 | ||
| CommonStockIssuance | 0.00 | 0.00 | ||
| NetIssuancePaymentsOfDebt | 71.00K | 71.00K | 30.95M | 19.07M |
| NetLongTermDebtIssuance | 71.00K | 71.00K | 30.95M | 19.07M |
| LongTermDebtPayments | -88.41M | -88.41M | 0.00 | -29.40M |
| LongTermDebtIssuance | 88.48M | 88.48M | 30.95M | 48.47M |
| InvestingCashFlow | -1.61M | -1.61M | -1.55M | -912.00K |
| CashFlowFromContinuingInvestingActivities | -1.61M | -1.61M | -1.55M | -912.00K |
| NetPPEPurchaseAndSale | -1.61M | -1.61M | -1.55M | -912.00K |
| PurchaseOfPPE | -1.61M | -1.61M | -1.55M | -912.00K |
| OperatingCashFlow | -63.98M | -63.98M | -46.98M | -14.33M |
| CashFlowFromContinuingOperatingActivities | -63.98M | -63.98M | -46.98M | -14.33M |
| InterestPaidCFO | -1.09M | -1.09M | 0.00 | |
| ChangeInWorkingCapital | 194.00K | 194.00K | -13.79M | -1.50M |
| ChangeInOtherCurrentLiabilities | -789.00K | -789.00K | -733.00K | 0.00 |
| ChangeInPayablesAndAccruedExpense | 5.72M | 5.72M | 11.49M | 2.09M |
| ChangeInAccruedExpense | 1.06M | 1.06M | 8.16M | 2.57M |
| ChangeInPayable | 4.66M | 4.66M | 3.32M | -488.00K |
| ChangeInAccountPayable | 4.66M | 4.66M | 3.32M | -488.00K |
| ChangeInPrepaidAssets | 285.00K | 285.00K | -577.00K | -1.37M |
| ChangeInInventory | -3.71M | -3.71M | -1.15M | -1.28M |
| ChangeInReceivables | -1.32M | -1.32M | -22.82M | -927.00K |
| ChangesInAccountReceivables | -1.32M | -1.32M | -22.82M | -927.00K |
| OtherNonCashItems | -4.96M | -4.96M | 2.06M | -321.00K |
| StockBasedCompensation | 8.36M | 8.36M | 437.00K | 313.00K |
| UnrealizedGainLossOnInvestmentSecurities | 4.40M | 0.00 | ||
| ProvisionandWriteOffofAssets | 14.07M | 14.07M | 436.00K | 220.00K |
| DepreciationAmortizationDepletion | 746.00K | 746.00K | 895.00K | 707.00K |
| DepreciationAndAmortization | 746.00K | 746.00K | 895.00K | 707.00K |
| Depreciation | 746.00K | 746.00K | 895.00K | 707.00K |
| OperatingGainsLosses | -693.00K | -2.88M | 726.00K | -1.37M |
| GainLossOnInvestmentSecurities | -4.44M | -6.63M | 839.00K | 240.00K |
| NetForeignCurrencyExchangeGainLoss | -180.00K | -180.00K | -113.00K | |
| NetIncomeFromContinuingOperations | -80.61M | -82.82M | -37.74M | -12.39M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ALUR
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|